Clinical characteristics and outcomes of diabetes‐related ketoacidosis ( DKA ) in sodium‐glucose co‐transporter‐2 inhibitor ( SGLT2i ) users with type 2 diabetes

Documenti analoghi

• DEKODE—A cloud‐based performance feedback model improved DKA care across multiple hospitals in the UK
  di: Lakshmi N. Rengarajan, et al.
  Pubblicazione: (2025)
• People with diabetes undergoing surgery: Level of knowledge of fluid prescribing in trainees in diabetes
  di: Ketan Dhatariya, et al.
  Pubblicazione: (2024)
• Lactated Ringer's versus normal saline in the management of acute diabetic ketoacidosis (RINSE‐DKA)
  di: Auriene Jamison, et al.
  Pubblicazione: (2024)
• Risk of recurrent diabetic ketoacidosis following initiation of sodium‐glucose co‐transporter 2 inhibitors in patients with an insulin‐deficient diabetes and prior diabetic ketoacidosis: An observational cohort study
  di: Anat Tsur, et al.
  Pubblicazione: (2026)
• Predictors of diabetic ketoacidosis in patients with insulin‐deficient diabetes phenotype initiating SGLT2 inhibitors
  di: Anat Tsur, et al.
  Pubblicazione: (2025)